These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 732817)

  • 1. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
    Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
    Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution of the radioactivity in the central nervous system of the developing rat following intracisternal or subcutaneous administration of 14C-5,7-dihydroxytryptamine.
    Sievers J; Baumgarten HG; Klemm HP; Schlossberger HG; Lolova I
    Bibl Anat; 1981; (19):302-7. PubMed ID: 7225075
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 4. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
    Stewart RM; Campbell A; Sperk G; Baldessarini RJ
    Psychopharmacology (Berl); 1979 Feb; 60(3):281-9. PubMed ID: 108706
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
    Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin neurotoxins: recent advances in the mode of administration and molecular mechanism of action.
    Baumgarten HG; Jenner S; Klemm HP
    J Physiol (Paris); 1981; 77(2-3):309-14. PubMed ID: 7288647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
    Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
    Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intracerebroventricular 5,7-dihydroxytryptamine on morphine analgesia is time-dependent.
    Romandini S; Pich EM; Esposito E; Kruszewska AZ; Samanin R
    Life Sci; 1986 Mar; 38(10):869-75. PubMed ID: 3951313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo binding properties of [carbonyl-11C]WAY-100635: effect of endogenous serotonin.
    Maeda J; Suhara T; Ogawa M; Okauchi T; Kawabe K; Zhang MR; Semba J; Suzuki K
    Synapse; 2001 May; 40(2):122-9. PubMed ID: 11252023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of substance P on the 5,7-dihydroxytryptamine induced alteration of the postnatal development of central serotonin neurons.
    Jonsson G; Hallman H
    Med Biol; 1983 Apr; 61(2):105-12. PubMed ID: 6192293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
    Fischette CT; Nock B; Renner K
    Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient depletion of serotonin in the nervous system of Helisoma.
    Gadotti D; Bauce LG; Lukowiak K; Bulloch AG
    J Neurobiol; 1986 Sep; 17(5):431-47. PubMed ID: 3021901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
    Kamei J; Ogawa M; Kasuya Y
    Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.
    Saller CF; Stricker EM
    Neuropharmacology; 1978 Jul; 17(7):499-506. PubMed ID: 692815
    [No Abstract]   [Full Text] [Related]  

  • 15. Alterations in serotonin binding sites after 5,7-dihydroxytryptamine treatment in the rat spinal cord.
    Brown LM; Smith DL; Williams GM; Smith DJ
    Neurosci Lett; 1989 Jul; 102(1):103-7. PubMed ID: 2779841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of body weight changes after selective serotonin depletion with 5,7-dihydroxytryptamine.
    Baez LA; Browning RA; Cusatis M
    Prog Neuropsychopharmacol; 1980; 4(2):123-7. PubMed ID: 7403347
    [No Abstract]   [Full Text] [Related]  

  • 17. Developmental plasticity of central serotonin neurons after 5,7-dihydroxytryptamine treatment.
    Jonsson G; Pollare T; Hallman H; Sachs C
    Ann N Y Acad Sci; 1978 Jun; 305():328-45. PubMed ID: 280250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the local administration of 5,7-DHT and 6-OHDA into the neocortex on the learning and exploratory behavior of rats in an open field].
    Ismaĭlova KhIu; Gasanov GG; Semenova TP; Bobkova NV; Nesterova IV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(3):548-55. PubMed ID: 2552698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of [3H]imipramine binding sites in rat brain regions: effect of neonatal 5,7-dihydroxytryptamine treatment.
    Hrdina PD; Pappas BA; Bialik RJ; Ryan CL
    Eur J Pharmacol; 1982 Sep; 83(3-4):343-4. PubMed ID: 7173315
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone.
    McIntyre IM; Oxenkrug GF; Stanley M; Gershon S
    Brain Res; 1984 Aug; 309(1):156-8. PubMed ID: 6488005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.